Title: Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with
gastric cancer
Version: 2 Date: 30 Nov 2021
Reviewer's report:
- The authors include patients with low muscle mass in the same group (sarcopenic) of patients
with low muscle mass and function. The results may change if the analyzes are done with two
groups separately. The authors should do the analyses separately for the two groups.
- Table 1: Please replace “Fmale” to “Female”.
- Table 2: Please replace  “Hypoproteinemia" to "anemia"
- The authors should consider other variables in multiple cox regression analysis (age, BMI,
etc)...
Title: Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with
gastric cancer
Version: 2 Date: 30 Nov 2021
Reviewer's report:
- The authors include patients with low muscle mass in the same group (sarcopenic) of patients
with low muscle mass and function. The results may change if the analyzes are done with two
groups separately. The authors should do the analyses separately for the two groups.
- Table 1: Please replace “Fmale” to “Female”.
- Table 2: Please replace  “Hypoproteinemia" to "anemia"
- The authors should consider other variables in multiple cox regression analysis (age, BMI,
etc)...
Please review this paper.
user
Title: Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with
gastric cancer
Version: 2 Date: 30 Nov 2021
Reviewer's report:
- The authors include patients with low muscle mass in the same group (sarcopenic) of patients
with low muscle mass and function. The results may change if the analyzes are done with two
groups separately. The authors should do the analyses separately for the two groups.
- Table 1: Please replace “Fmale” to “Female”.
- Table 2: Please replace  “Hypoproteinemia" to "anemia"
- The authors should consider other variables in multiple cox regression analysis (age, BMI,
etc)...
assistant